Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?

Gynecologic Oncology

Volumn 131, Issue 3, 2013, Pages 629-633

  Ricci, Stephanie ^a   Giuntoli II, Robert L ^a   Eisenhauer, Eric ^b   Lopez, Micael A ^c   Krill, Lauren ^a   Tanner III, Edward J ^a   Gehrig, Paola A ^d   Havrilesky, Laura J ^c   Secord, Angeles Alvarez ^c   Levinson, Kimberly ^a   Frasure, Heidi ^e   Celano, Paul ^f   Fader, Amanda Nickles ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^f GREATER BALTIMORE MEDICAL CENTER   (United States)

Author keywords

Adjuvant therapy; Chemotherapy; Uterine leiomyosarcoma

Indexed keywords

CISPLATIN; DOCETAXEL; DOXORUBICIN; GEMCITABINE; IFOSFAMIDE; MESNA; TOPOTECAN;

ADJUVANT THERAPY; ADULT; ARTICLE; BODY MASS; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; SURVIVAL RATE; UTERUS SARCOMA;

ADJUVANT THERAPY; CHEMOTHERAPY; UTERINE LEIOMYOSARCOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DEOXYCYTIDINE; FEMALE; HUMANS; LEIOMYOSARCOMA; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TAXOIDS; UTERINE NEOPLASMS;

EID: 84888307958     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.08.037     Document Type: Article

References (19)

1. A. Gadducci, F. Landoni, E. Sartori, P. Zola, T. Maggino, and A. Lissoni Uterine leiomyosarcoma: analysis of treatment failures and survival Gynecol Oncol 62 1996 25 32
2. T.A. Dinh, E.A. Oliva, A.F. Fuller, H. Lee, and A. Goodman The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital Gynecol Oncol 92 2004 648 652
3. T. Wu, T.C. Chang, S. Hsueh, K.H. Hsu, H.H. Chou, and H.J. Huang Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma Gynecol Oncol 100 2006 166 172
4. M. Leitao, O. Zivanovic, D.S. Chi, M.L. Hensley, R. O'Cearbhaill, and R.A. Soslow Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis Gynecol Oncol 125 2012 409 413
5. F.J. Major, J.A. Blessing, S.G. Silverberg, C.P. Morrow, W.T. Creasman, and J.L. Currie Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study Cancer 71 1993 1702
6. D.S. Kapp, J.Y. Shin, and J.K. Chan Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy Cancer 112 2008 820
7. R.L. Giuntoli, D.S. Metzinger, C.S. DiMarco, S.S. Cha, J.A. Sloan, and G.L. Keeney Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management and adjuvant therapy Gynecol Oncol 89 2003 460
8. N.S. Reed, C. Mangioni, H. Malmström, G. Scarfone, A. Poveda, and S. Pecorelli Phase III randomized study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organization for Research and Treatment of Cancer; Gynaecological Cancer Group Study Eur J Cancer 44 6 Apr 2008 808 818
9. G. Sutton, J.A. Blessing, and J.H. Malfetano Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study Gynecol Oncol 62 1996 226
10. M.L. Hensley, N. Ishill, R. Soslow, J. Larkin, N. Abu-Rustum, and P. Sabbatini Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: results of a prospective study Gynecol Oncol 112 2009 563
11. M.L. Hensley, J.A. Blessing, R. Mannel, and P.G. Rose Fixed dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study Gynecol Oncol 109 2008 329 334
12. M.L. Hensley, R. Maki, E. Venkatraman, G. Geller, M. Lovegren, and C. Aghajanian Gemcitabine and docetaxel in patients with unresectable uterine leiomyosarcoma: results of a phase II trial J Clin Oncol 20 12 2002 2824 2831
13. K.Y. Look, A. Sandler, J.A. Blessing, J.A. Lucci, and P.G. Rose Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) study Gynecol Oncol 92 2004 644 647
14. S.W. Bell, R.L. Kempson, and M.R. Hendrickson Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases Am J Surg Pathol 18 6 1994 535
15. G.A. Omura, J.A. Blessing, F. Major, S. Lifshitz, C.E. Ehrlich, and C. Mangan A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study J Clin Oncol 3 9 1985 1240
16. M.L. Hensley, J.K. Wathen, R.G. Maki, D.M. Araujo, G. Sutton, and D.A. Priebat Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005) Cancer 119 8 Apr 15 2013 1555 1561
17. B.J. Monk, J.A. Blessing, D.G. Street, C.Y. Muller, J.J. Burke, and M.L. Hensley A phase II evaluation of trabectedin in the treatment of advanced, persistent or recurrent uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) study Gynecol Oncol 124 2012 48 52
18. W.T. van der Graaf, J.Y. Blay, S.P. Chawla, D.W. Kim, B. Bui-Nguyen, and P.G. Casali EORTC Soft Tissue and Bone Sarcoma Group; PALETTE study group. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial Lancet 379 9829 2012 1879
19. R. O'Cearbhaill, Q. Zhou, A. Iasonos, R.A. Soslow, M.M. Leitao, and C. Aghajanian Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors Gynecol Oncol 116 3 2010 424